» Articles » PMID: 2573506

Rational Use of Antihistamines in Allergic Dermatological Conditions

Overview
Journal Drugs
Specialty Pharmacology
Date 1989 Oct 1
PMID 2573506
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

For many years, the use of antihistamines in dermatological conditions has been closely linked to the treatment of urticarias and to the symptomatic relief of pruritus. H1-receptor antagonists are the first-line drugs for urticarias. Those urticarias of type I immunological origin respond better than physical urticarias. H2-receptor antagonists may be added for refractory patients but are rarely effective alone. Conventional H1-blockers are frequently associated with somnolence and anticholinergic effects. Therefore, new antihistamines without depressive effects on the central nervous system have recently been introduced. In other pruritic conditions such as atopic dermatitis the limited effects of these drugs suggest that histamine is not the only mediator involved in pruritus. In these cases, their beneficial effects seem to be due mainly to their sedative properties; recently available nonsedative H1-blockers are less effective.

Citing Articles

Effect of a few histamine(1)-antagonists on blood glucose in patients of allergic rhinitis.

Lal A Indian J Otolaryngol Head Neck Surg. 2012; 52(2):193-5.

PMID: 23119674 PMC: 3451290. DOI: 10.1007/BF03000353.


Public health problems and the rapid estimation of the size of the population at risk. Torsades de pointes and the use of terfenadine and astemizole in The Netherlands.

Herings R, Stricker B, Leufkens H, Bakker A, Sturmans F, Urquhart J Pharm World Sci. 1993; 15(5):212-8.

PMID: 8257958 DOI: 10.1007/BF01880629.


Influence of histamine receptor antagonists on the dynamics of the cutaneous hypersensitivity reaction in patients infected with schistosoma haematobium.

Snyman J, Sommers D, Gregorowski M Eur J Clin Pharmacol. 1993; 44(5):467-71.

PMID: 8102968 DOI: 10.1007/BF00315545.


Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.

Desager J, Horsmans Y Clin Pharmacokinet. 1995; 28(5):419-32.

PMID: 7614779 DOI: 10.2165/00003088-199528050-00006.

References
1.
Granerus G, Wass U . Urinary excretion of histamine, methylhistamine (1-MeHi) and methylimidazoleacetic acid (MeImAA) in mastocytosis: comparison of new HPLC methods with other present methods. Agents Actions. 1984; 14(3-4):341-5. DOI: 10.1007/BF01973823. View

2.
BRODY M . Evidence for non-mast cell histamine in the vascular wall. Blood Vessels. 1975; 12(3):181-91. DOI: 10.1159/000158049. View

3.
Ruzicka T, Gluck S . Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome. Arch Dermatol Res. 1983; 275(1):41-4. DOI: 10.1007/BF00516553. View

4.
Mamus S, Mladenovic J, Hordinsky M, Dahl M, Kay N . Cimetidine-induced remission of mycosis fungoides. Lancet. 1984; 2(8399):409. DOI: 10.1016/s0140-6736(84)90580-4. View

5.
Eady R, Cowen T, Marshall T, Plummer V, Greaves M . Mast cell population density, blood vessel density and histamine content in normal human skin. Br J Dermatol. 1979; 100(6):623-33. DOI: 10.1111/j.1365-2133.1979.tb08065.x. View